Trials / Completed
CompletedNCT03596034
A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers
A Study to Characterize Puff Topography With Use of a JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Juul Labs, Inc. · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A Study to Characterize Puff Topography with Use of a JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers
Detailed description
This will be an open label study to evaluate puff topography in adult smokers using a JUUL 5% ENDS. Up to 30 subjects will be enrolled and evaluated on Day 1 and Day 15. The duration of the study is 15 days with up to a 28 days screening window.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | JUUL 5%, Virginia Tobacco, ENDS product | Subjects participate in a 15 day product use period during which subjects will be requested to predominantly use the JUUL 5% product ad libitum as their primary source of nicotine. Subjects will be asked to report their daily use of the JUUL 5% product and CPD throughout the 15 day product use period. |
Timeline
- Start date
- 2018-08-09
- Primary completion
- 2018-09-26
- Completion
- 2018-09-26
- First posted
- 2018-07-23
- Last updated
- 2021-06-14
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03596034. Inclusion in this directory is not an endorsement.